Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Aytu BioScience stock (AYTU)

Buy Aytu BioScience stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Aytu BioScience is a drug manufacturers - specialty & generic business based in the US. Aytu BioScience shares (AYTU) are listed on the NASDAQ and all prices are listed in US Dollars. Aytu BioScience employs 150 staff and has a trailing 12-month revenue of around $93.8 million.

Our top picks for where to buy Aytu BioScience stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Aytu BioScience stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – AYTU. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Aytu BioScience stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 3.1 / 5: ★★★★★
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Aytu BioScience stock price (NASDAQ: AYTU)

Use our graph to track the performance of AYTU stocks over time.

Aytu BioScience shares at a glance

Information last updated 2024-07-22.
Latest market close$2.79
52-week range$1.52 - $3.50
50-day moving average $2.99
200-day moving average $2.87
Wall St. target price$8.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.44

Is it a good time to buy Aytu BioScience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aytu BioScience price performance over time

Historical closes compared with the close of $2.79 from 2024-07-19

1 week (2024-07-16) -0.36%
1 month (2024-06-21) -4.12%
3 months (2024-04-23) 2.76%
6 months (2024-01-23) 1.45%
1 year (2023-07-21) 54.14%
2 years (2022-07-22) 391.28%
3 years (2021-07-23) 4.1
5 years (2019-07-23) 17.1

Is Aytu BioScience stock undervalued or overvalued?

Valuing Aytu BioScience stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aytu BioScience's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Aytu BioScience's EBITDA

Aytu BioScience's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9.9 million.

The EBITDA is a measure of a Aytu BioScience's overall financial performance and is widely used to measure a its profitability.

Aytu BioScience financials

Revenue TTM $93.8 million
Gross profit TTM $66.6 million
Return on assets TTM 0.66%
Return on equity TTM -38.18%
Profit margin -14.6%
Book value $5.53
Market Capitalization $16.8 million

TTM: trailing 12 months

Aytu BioScience share dividends

We're not expecting Aytu BioScience to pay a dividend over the next 12 months.

Have Aytu BioScience's shares ever split?

Aytu BioScience's shares were split on a 1:20 basis on 5 January 2023. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aytu BioScience shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Aytu BioScience shares which in turn could have impacted Aytu BioScience's share price.

Aytu BioScience share price volatility

Over the last 12 months, Aytu BioScience's shares have ranged in value from as little as $1.52 up to $3.5. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aytu BioScience's is -1.412. This would suggest that Aytu BioScience's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aytu BioScience has bucked the trend.

Aytu BioScience overview

Aytu Biopharma, Inc. , a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment. The Rx segment offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years and older, and Cotempla XR-ODT for patients from six to seventeen years old. The segment also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The Consumer Health segment is involved in the commercialization of over-the-counter medicines, personal care products, and dietary supplements in various categories, such as hair loss, digestive health, urological health, diabetes management, and allergy. The segment offers Regoxidine - for Men and Women, a proprietary over-the-counter aerosol foam that works to treat hair loss in both men and women; and OmepraCareDR and EsomepraCareDR, acid reducers for the treatment of frequent heartburn.

Frequently asked questions

What percentage of Aytu BioScience is owned by insiders or institutions?
Currently 3.331% of Aytu BioScience shares are held by insiders and 30.112% by institutions.
How many people work for Aytu BioScience?
Latest data suggests 150 work at Aytu BioScience.
When does the fiscal year end for Aytu BioScience?
Aytu BioScience's fiscal year ends in June.
Where is Aytu BioScience based?
Aytu BioScience's address is: Denver Corporate Center III, Denver, CO, United States, 80237
What is Aytu BioScience's ISIN number?
Aytu BioScience's international securities identification number is: US0547548745
What is Aytu BioScience's CUSIP number?
Aytu BioScience's Committee on Uniform Securities Identification Procedures number is: 054754205

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site